Clinical Trial Update: Autologous Serum Obtained by a Closed-Circuit Collection Device [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating autologous serum obtained by a closed-circuit collection device for several ocular surface diseases; recruitment has not yet b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosions of Persistent Epithelial Defects
• Graft-versus-host Disease
• Limbal Keratoconjunctivitis
• Meibomian Gland Dysfunction
• Neurotrophic Ulcer
• Sjogren Syndrome with Keratoconjunctivitis
• Stevens-johnson Syndrome

Drugs mentioned

• Autologous serum obtained by a closed-circuit collection device (autologous serum)

Snippet

Sponsor: GIANCARLO FATOBENE | Conditions: GVHD, Meibomian Gland Dysfunction (Disorder) | Phase 2 | Status: NOT_YET_RECRUITING